Company registration number 07349488 (England and Wales)
MWK HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2026
PAGES FOR FILING WITH REGISTRAR
MWK HEALTHCARE LIMITED
COMPANY INFORMATION
Director
D M W Keeling
Secretary
D M W Keeling
Company number
07349488
Registered office
F09 The Fort Offices
Artillery Business Park
Oswestry
Salop
United Kingdom
SY11 4AD
Accountants
Sedulo Accountants Limited
62-66 Deansgate
Manchester
United Kingdom
M3 2EN
MWK HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MWK HEALTHCARE LIMITED
BALANCE SHEET
AS AT
30 APRIL 2026
30 April 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
5
78
140
Current assets
Stocks
6,720
6,599
Debtors
6
26,494
95,941
Cash at bank and in hand
52,653
6,467
85,867
109,007
Creditors: amounts falling due within one year
7
(72,155)
(87,700)
Net current assets
13,712
21,307
Total assets less current liabilities
13,790
21,447
Creditors: amounts falling due after more than one year
8
-
0
(333)
Provisions for liabilities
(15)
(13)
Net assets
13,775
21,101
Capital and reserves
Called up share capital
200
200
Profit and loss reserves
13,575
20,901
Total equity
13,775
21,101
MWK HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2026
30 April 2026
- 2 -

For the financial year ended 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 5 August 2026
D M W Keeling
Director
Company registration number 07349488 (England and Wales)
MWK HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2026
30 April 2026
- 3 -
1
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

2
Accounting policies
Company information

MWK Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is F09 The Fort Offices, Artillery Business Park, Oswestry, Salop, United Kingdom, SY11 4AD.

2.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

2.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

2.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

2.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
five years
Development costs
five years
MWK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2026
2
Accounting policies
(Continued)
- 4 -
2.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% on cost
Computers
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

2.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

2.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

2.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

MWK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
2
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

2.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2.12
Leases
As lessee
MWK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
2
Accounting policies
(Continued)
- 6 -

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease.

2.13
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
4
4
4
Intangible fixed assets
Patents & licences
Development costs
Total
£
£
£
Cost
At 1 May 2025 and 30 April 2026
7,221
35,184
42,405
Amortisation and impairment
At 1 May 2025 and 30 April 2026
7,221
35,184
42,405
Carrying amount
At 30 April 2026
-
0
-
0
-
0
At 30 April 2025
-
0
-
0
-
0
5
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 May 2025 and 30 April 2026
190
249
439
Depreciation and impairment
At 1 May 2025
190
109
299
Depreciation charged in the year
-
0
62
62
At 30 April 2026
190
171
361
MWK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
5
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
(Continued)
- 7 -
Carrying amount
At 30 April 2026
-
0
78
78
At 30 April 2025
-
0
140
140
6
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
26,494
95,941
7
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans
596
4,262
Trade creditors
4,915
3,348
Corporation tax
2,075
4,893
Other taxation and social security
(2,203)
8,337
Other creditors
66,772
66,860
72,155
87,700
8
Creditors: amounts falling due after more than one year
2026
2025
£
£
Bank loans and overdrafts
-
0
333
9
Directors' transactions

Included within other creditors is an amount owed to the directors of £37 (2025: £37).

The loans are interest free and there are no fixed repayment terms.

2026-04-30 2025-05-01 false false false 05 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity D M W Keeling D M W Keeling 07349488 2025-05-01 2026-04-30 07349488 bus:CompanySecretaryDirector1 2025-05-01 2026-04-30 07349488 bus:CompanySecretary1 2025-05-01 2026-04-30 07349488 bus:Director1 2025-05-01 2026-04-30 07349488 bus:RegisteredOffice 2025-05-01 2026-04-30 07349488 2026-04-30 07349488 2025-04-30 07349488 core:FurnitureFittings 2026-04-30 07349488 core:ComputerEquipment 2026-04-30 07349488 core:FurnitureFittings 2025-04-30 07349488 core:ComputerEquipment 2025-04-30 07349488 core:CurrentFinancialInstruments core:WithinOneYear 2026-04-30 07349488 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 07349488 core:Non-currentFinancialInstruments core:AfterOneYear 2026-04-30 07349488 core:Non-currentFinancialInstruments core:AfterOneYear 2025-04-30 07349488 core:CurrentFinancialInstruments 2026-04-30 07349488 core:CurrentFinancialInstruments 2025-04-30 07349488 core:ShareCapital 2026-04-30 07349488 core:ShareCapital 2025-04-30 07349488 core:RetainedEarningsAccumulatedLosses 2026-04-30 07349488 core:RetainedEarningsAccumulatedLosses 2025-04-30 07349488 core:IntangibleAssetsOtherThanGoodwill 2025-05-01 2026-04-30 07349488 core:PatentsTrademarksLicencesConcessionsSimilar 2025-05-01 2026-04-30 07349488 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-05-01 2026-04-30 07349488 core:FurnitureFittings 2025-05-01 2026-04-30 07349488 core:ComputerEquipment 2025-05-01 2026-04-30 07349488 2024-05-01 2025-04-30 07349488 core:PatentsTrademarksLicencesConcessionsSimilar 2025-04-30 07349488 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-30 07349488 2025-04-30 07349488 core:PatentsTrademarksLicencesConcessionsSimilar 2026-04-30 07349488 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2026-04-30 07349488 core:PatentsTrademarksLicencesConcessionsSimilar 2025-04-30 07349488 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-30 07349488 core:FurnitureFittings 2025-04-30 07349488 core:ComputerEquipment 2025-04-30 07349488 core:Non-currentFinancialInstruments 2026-04-30 07349488 core:Non-currentFinancialInstruments 2025-04-30 07349488 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 07349488 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 07349488 bus:FRS102 2025-05-01 2026-04-30 07349488 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 07349488 bus:FullAccounts 2025-05-01 2026-04-30 xbrli:pure xbrli:shares iso4217:GBP